Open
20/20從醫(yī)療院所收集大量的臨床癌癥腫瘤標(biāo)記資料，並透過運(yùn)用先進(jìn)的技術(shù)進(jìn)行分析。
20/20's innovative business model uses advanced analytics on large volumes of real world,clinically revelent patient health data collected from hospital centers where tumor biomaker testing has been used for many years.
20/20's innovative business model uses advanced analytics on large volumes of real world,clinically revelent patient health data collected from hospital centers where tumor biomaker testing has been used for many years.